Both U.S. and Chinese participants with stronger insulin resistance (as evaluated by the TyG index), worsened lipid profiles (as estimated by non-HDL-C levels), and greater inflammation status (as assessed by CRP levels) demonstrated a worse status of arterial stiffness than did the reference groups. Here, CRP is linked to Insulin resistance.